|

Valbenazine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NBI-98854

Pipeline

Phase 4: 1

Top Sponsors

  • Neurocrine Biosciences1

Indications

  • Tardive Dyskinesia1
  • Schizoaffective Disorder1
  • Major Depressive Disorder1
  • Bipolar Disorder1
  • Schizophrenia1

Bryant, Arkansas1 trial

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.